Phaos Technology Holdings (Caym (POAS)
NYSE American · Healthcare · Medical Devices
$0.1449+3.50%as of Oct 6, 2026, 4:35 AM ET
- Market cap
- $4.6M
- 52-week range
- $0.132 – $7.40
- 52-week change
- −96.36%
- EPS (trailing)
- −$0.38
Fiscal year to Apr 2026
- Revenue
- $104K (−19.28%)
- Net income
- −$4.8M
- Operating margin
- −4706.9%
- Diluted EPS
- −$0.38
- Free cash flow
- −$8.6M
From the company’s annual report on SEC EDGAR.
About Phaos Technology Holdings (Caym
Phaos Technology Holdings (Cayman) Limited, through its subsidiary, Phaos Technology Pte. Ltd., engages in the manufacturing and commercialization of advanced microscopy-related solutions, technologies, and products in Singapore. The company offers Optonano that enables users to view live and still images for construction of high-quality image of larger sample areas; PT-Industrial for use in material study, failure analysis, simple measuring, quality control, inspection, and manufacturing; and PT-Metrology, which provides dimensional measurements with a single key operation. It also provides PT-Biology to create specialized images needed in the biomedical sector; PT-Stereo, a stereo microscope designed to provide clear magnified stereoscopic images that amplify solid or thick samples; and PT-Zoom that offers three-dimensional magnified view of samples to enhance visualization. In addition, the company offers software services. It serves manufacturing companies; biomedical service providers; and research and development institutions. Phaos Technology Holdings (Cayman) Limited was founded in 2017 and is based in Singapore.
Headquarters: Singapore, Singapore · 10 employees · phaostech.com